Buy LYNPARZA (Olaparib 50mg) Capsules online with best price

Medical Uses

Lynparza (Olaparib 100 mg/150 mg) is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated for:

Ovarian Cancer Treatment:

Maintenance Treatment for BRCA-mutated Cancer: This treatment is for adults with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer with confirmed or suspected BRCA mutations. It is intended for those with a complete or partial response to first-line platinum-based chemotherapy.
Combination Treatment with Bevacizumab: For adults with HRD-positive advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer, this treatment combines with bevacizumab for patients responding to first-line platinum-based chemotherapy. A deleterious BRCA mutation or genomic instability defines HRD-positive status.
Treatment for Recurrent BRCA-mutated Cancer: This is aimed at adults with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer with BRCA mutations, who have responded to platinum-based chemotherapy.

Breast Cancer Treatment:

Early Breast Cancer: For adults with HER2-negative, high-risk early breast cancer who have a deleterious or suspected deleterious gBRCA mutation and have received neoadjuvant or adjuvant chemotherapy.
Metastatic Breast Cancer: For adults with HER2-negative metastatic breast cancer who have a deleterious or suspected deleterious gBRCA mutation and have been treated with chemotherapy in the neoadjuvant, adjuvant, or metastatic setting. Patients with HR-positive breast cancer should have previously received endocrine therapy or been deemed unsuitable for it.

Pancreatic Cancer Treatment:

Maintenance treatment for adult patients with harmful or potentially harmful gBRCAm metastatic pancreatic adenocarcinoma, whose disease has remained stable after at least 16 weeks of first-line platinum-based chemotherapy.

Prostate Cancer Treatment:

For adult patients with germline or somatic HRR gene-mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed after treatment with enzalutamide or abiraterone.
In combination with abiraterone and prednisone or prednisolone for adult patients with BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC).

Recommended Dosage: The recommended dosage of Lynparza tablets is 300 mg, taken orally twice a day, with or without food. Patients with metastatic castration-resistant prostate cancer (mCRPC) should also use a gonadotropin-releasing hormone (GnRH) analog concurrently or have undergone a bilateral orchiectomy. For patients with moderate renal impairment (creatinine clearance of 31-50 mL/min), the dosage should be reduced to 200 mg orally twice daily.

If a patient misses a dose of Lynparza, they should take the next dose at the regular scheduled time. Patients should be advised to swallow the tablets whole without chewing, crushing, dissolving, or dividing them.

Warning & Precautions

Patients treated with Olaparib 100 mg/150 mg tablets may develop MDS/AML, a potentially fatal condition. Monitor patients for hematological toxicity at baseline and monthly thereafter. Signs of MDS/AML include persistent cytopenias, infections, and bleeding. Discontinue this treatment if MDS/AML is confirmed.
Treatment with Olaparib has been associated with pneumonitis, which can be fatal. Symptoms include shortness of breath, cough, and fever. If pneumonitis is suspected, interrupt treatment and promptly evaluate the patient. Permanently discontinue Olaparib in case pneumonitis is confirmed.
This therapeutic drug has been associated with an increased risk of venous thromboembolism, including pulmonary embolism and deep vein thrombosis, which may be life-threatening or fatal. Patients should be monitored for signs and symptoms of venous thromboembolism.
Lynparza 100 mg/150 mg can cause fetal harm when administered to pregnant women. Advise patients of reproductive potential to use effective contraception during treatment and for at least six months after the last dose. If pregnancy occurs during treatment, inform the patient of the potential risk to the fetus.
There is no information on the presence of Lynparza in human milk or its effects on breastfed infants. Due to the potential for serious adverse reactions in nursing infants, women should be advised not to breastfeed during treatment with Olaparib and for one month after the last dose.

Documentation & Availability

What documents are required to import LYNPARZA to India?

LYNPARZA (olaparib) tablets can be imported by patients or government hospitals on the name of the patients only.

The following documentation are needed to import the product:

A valid prescription from a qualified doctor.
Patient’s diagnostic reports.
Patient’s ID proof (issued by the Government of India).

How is the order confirmed?

The order will be confirmed only after the receipt of:

A valid prescription from a doctor.
Import permit if applicable.

Is LYNPARZA available in India?

LYNPARZA (olaparib tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is the facilitator providing input:

On availability of Lynparza in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
Medicine Price.
Finding Genuine and reliable sources from Canada, Europe, the USA, and Australia
Ensuring 100% transparency.

LYNPARZA can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

S S Healthcare (S S Healthcare) can facilitate the supply of LYNPARZA (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-7575883015 or write us at sshealthcare1012@gmail.com for Lynparza 100 mg/150 mg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Sourcing & Delivery

S S Healthcare can source LYNPARZA (a cancer treatment medication) from across the globe and supply it to India and other countries where the medicine is not yet approved or unavailable. Through our services, we ensure that patients have worldwide access to the best available treatments.

S S Healthcare is capable of dispensing any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the patient’s address directly from New Delhi, India.

FAQ

What is the Generic Name for the trade name drug Lynparza®?

Olaparib is the Generic Name for the trade name drug Lynparza®.

What is the Manufacturer’s Name of Lynparza®?

Lynparza® is jointly manufactured and commercialized by AstraZeneca and MSD.

Is Lynparza® approved by the FDA?

Yes, Lynparza® is approved by the FDA. Date of first approval: December 19, 2014.

What is the dosage and form of Lynparza® supplied?

Lynparza® is supplied as Tablets: 150 mg, and 100 mg for oral administration.

What are the most common side effects of Lynparza®?

The most common side effects of Lynparza®

as a single agent are vomiting, diarrhea, nausea, fatigue, anemia, decreased appetite, headache, leukopenia, dizziness, dysgeusia, cough, neutropenia, dyspnea, dyspepsia, and thrombocytopenia.
in combination with bevacizumab are vomiting, nausea, fatigue, anemia, lymphopenia, diarrhea, leukopenia, neutropenia, urinary tract infection, and headache.
in combination with abiraterone and prednisone or prednisolone are anemia, nausea, dizziness, fatigue, diarrhea, decreased appetite, lymphopenia, and abdominal pain.

Where can I Access Lynparza® (Olaparib tablets) at the best price in India?

S S Healthcare, a certified pharmaceutical facilitator/supplier/importer and WHO-GDP certified offers “Lynparza (Olaparib tablets)” in India. Although FDA-approved Olaparib (brand name Lynparza) is not yet registered in India, Indian patients can purchase it upon request at the lowest price. To confirm an order for Lynparza, a valid doctor’s prescription and, if required, an import permit must be submitted.

How much does Lynparza® (Olaparib tablets) cost in India?

Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on Olaparib 100 mg/150 mg cost in India, it is recommended to Call/WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.

Can Lynparza® (Olaparib tablets) be made available in SAARC countries?

Apart from Gulf countries, Lynparza® can be available in SAARC countries (Afghanistan, India, Bangladesh, Bhutan, Maldives, Nepal, Pakistan, and Sri Lanka). S S Healthcare can help facilitate the supply of Lynparza® (Olaparib tablets) in these countries, ensuring access to this therapeutic drug through legal and reliable channels.

Is it safe to buy Lynparza® (Olaparib tablets) online in India?

Yes, one can buy Lynparza (Olaparib tablets) online in India at the best price from the S S Healthcare if this medicinal product is not registered or is unavailable in their country. We can help facilitate the supply of Lynparza® tablets through legal channels.

What are the storage conditions of Lynparza®?

Store at 20 to 25°C (68 to 77°F), excursions permitted to 15 to 30°C (59 to 86°F). Store in original bottle to protect from moisture

In India, where has the S S Healthcare imported and delivered anti-cancer medicines, including FDA-approved Olaparib (brand name Lynparza)?

For personal use, FDA-approved Olaparib (brand name Lynparza) can be accessed in India through our services. We have successfully imported and delivered anti-cancer medicines to these cities: Bangalore, Ahmedabad, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi,, Gurugram, Delhi Amaravati, Itanagar, Dispur, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain, Aurangabad, Barshi, Cachar, Dibrugarh, Kollam, Meghalaya, Mizoram, Sikkim, Puducherry, Punjab, Tripura, New Delhi, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad, etc.

FAQs for Generic Brand Bracanat (Olaparib 100 mg/150 mg)

What is Bracanat (Olaparib 100 mg/150 mg)?

Bracanat is an Indian generic brand that serves as an alternative to the brand-name medication Lynparza. It contains the active ingredient Olaparib, which is used for the treatment and management of ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.

Is Bracanat (Olaparib) available for export from India?

Yes, we are a leading exporter of Bracanat (generic Lynparza) from India to various regions worldwide, including Asia, Australia, North America, South America, Central America, Eastern Europe, Western Europe, the Middle East, and Africa.

How can healthcare providers or patients access Bracanat (Olaparib) from India?

To buy Olaparib 100 mg/150 mg from India, healthcare providers or patients must provide a valid prescription and comply with the import regulations of the destination country. The S S Healthcare assists in navigating these requirements to ensure smooth delivery.

Where can I get Bracanat (Olaparib 100 mg/150 mg) at the best Price?

Order Olaparib at the best price today. We request that you Call/WhatsApp us at +91-7575883015, dial our Number: +91-7575883015, or write to us at sshealthcare1012@gmail.com. We are fully committed to providing you with the best Olaparib 100 mg/150 mg price from India. That is why we’ll match the cost/price of any other facilitators/suppliers/distributors in the market who require a valid medical prescription.

Is the Bracanat (Olaparib 100 mg/150 mg) available in India?

Bracanat (Olaparib) is a generic alternative to Lynparza and is available in India. It is a (prescription drug, doctor-prescribed medication, or health care professional-prescribed medicine) pharmaceutical drug that can be legally dispensed against a medical prescription. A generic version of Lynparza can be made available across the world through India’s authorized distributor network. (Ahmedabad, Mumbai, Kolkata, Hyderabad, Bangalore, Chennai, Delhi, Pune, etc.).

Can You Send the Bracanat (Olaparib 100 mg/150 mg) to Foreign Destinations?

Buy generic Olaparib online at the lowest price from a leading supplier/exporter. We can assist in the delivery of Olaparib; the doctor-prescribed medication to Austria, Belgium, France, Germany, Ireland, Luxembourg, Netherlands, Switzerland, the UK, Israel, Iraq, Jordan, Bahrain, Egypt, Iran, Kuwait, Qatar, Lebanon, Oman, Saudi Arabia, Syria, Turkey, UAE, Belize, Costa Rica, El Salvador, Guatemala, Italy, Czech Republic, Panama, Serbia, Slovakia, Slovenia, Ukraine, Russia, Bulgaria, Croatia, Estonia, Hungary, Kosovo, Latvia, Lithuania, Moldova, Poland, Romania, Belarus, Argentina, Brazil, Chile, Colombia, Guyana, Peru, Ecuador, Paraguay, Suriname, Uruguay, Venezuela, Canada, Mexico, US, Singapore, Japan, Sri Lanka, Indonesia, and China.

What is the procedure for buying Bracanat (Olaparib 100 mg/150 mg) from India?

Patients can simply fill out the order form or send mail to sshealthcare1012@gmail.com. Patients can also send WhatsApp messages to +91-7575883015 or dial the TOLL-FREE Number: 18008891064. We will reply ASAP with the details of the Olaparib 100 mg/150 mg price and the procurement procedure.

Note:- The order will be confirmed only after the valid receipt of the prescription from the Physician.

Is it safe to buy Bracanat (Olaparib) Tablets online from India?

Yes, one can buy Olaparib tablets online from India-based S S Healthcare if the medicinal product is not (yet) registered or is unavailable in their respective country. We can help facilitate the supply of generic Olaparib through legal channels.

What are the main export markets for Bracanat (Olaparib 100 mg/150 mg)?

The main export markets for Bracanat (Olaparib 100 mg/150 mg tabletss) are Western Europe (Austria, Belgium, France, Germany, Ireland, Liechtenstein, Luxembourg, Monaco, Netherlands, Switzerland, United Kingdom, Andorra), Australia, the Middle East (Bahrain, Cyprus, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, Turkey, UAE, Yemen), Central America (Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama), Eastern Europe (Serbia, Slovakia, Slovenia, Ukraine, Russia, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Kosovo, Latvia, Lithuania, Moldova, Montenegro, North Macedonia, Poland, Romania, Albania, Belarus, Bosnia, Herzegovina), South America (Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela), Asia (Vietnam, Thailand, Singapore, Sri Lanka, Philippines, Maldives, Malaysia, Japan, Indonesia, China, Bangladesh, Bhutan, Afghanistan), North America (Canada, Mexico, US, Cuba, Jamaica, Haiti, and Africa.

Lynparza(Olaparib)

Alternative Option: